Therapeutic Strategies in Schizophrenia:
Gespeichert in:
| 1. Verfasser: | |
|---|---|
| Format: | Elektronisch E-Book |
| Sprache: | English |
| Veröffentlicht: |
Oxford
Clinical Pub.
2010
|
| Schriftenreihe: | Therapeutic strategies
|
| Schlagworte: | |
| Online-Zugang: | FAW01 FAW02 Volltext |
| Beschreibung: | Contents; Editors; Contributors; Preface; Chapter 1: Medical side-effects of antipsychotic agents: hyperprolactinaemia and metabolic disorders; Chapter 2: Dual diagnosis; Chapter 3: Long-acting antipsychotic injections; Chapter 4: Novel antipsychotic drugs: the current climate; Chapter 5: Cognitive therapy for schizophrenia: does it work?; Chapter6: Treatment strategies in early psychosis; Chapter 7: Structural and functional brain imaging in schizophrenia: implications for pathophysiology; Chapter 8: Functional imaging with ligands in schizophrenia: therapeutic inferences Chapter 9: When monotherapy is insufficient: the role and effectiveness of additional drugs in schizophreniaChapter 10: The current status of clozapine in and beyond treatment-resistant schizophrenia; Chapter 11: Neurochemical theories of schizophrenia; Chapter 12: Second-generation atypical versus first generation conventional antipsychotic drug treatment in schizophrenia: another triumph of hope over experience?; Chapter 13: Second-generation antipsychotic drugs: mechanistically distinct or minor variants?; Chapter 14: Disturbed behaviour and its management; Abbreviations; Index Updates the reader on the therapeutic options available for the management of schizophrenia, aiding the clinician to translate scientific evidence into improved outcomes. This book also presents a thorough discussion of the new generation of 'atypical' antipsychotic drugs - their mode of action and their clinical efficacy in a range of applications. These new agents are compared with existing medications, guiding the reader on their use in combination with other treatments as part of an integrated programme of patient management. Additional special topics covered include metabolic side-effects Includes bibliographical references and index |
| Beschreibung: | 1 Online-Ressource (251 pages) |
| ISBN: | 1846920353 1846926122 9781846920356 9781846926129 |
Internformat
MARC
| LEADER | 00000nmm a2200000zc 4500 | ||
|---|---|---|---|
| 001 | BV043161160 | ||
| 003 | DE-604 | ||
| 005 | 00000000000000.0 | ||
| 007 | cr|uuu---uuuuu | ||
| 008 | 151126s2010 |||| o||u| ||||||eng d | ||
| 020 | |a 1846920353 |c electronic bk. |9 1-84692-035-3 | ||
| 020 | |a 1846926122 |9 1-84692-612-2 | ||
| 020 | |a 9781846920356 |c electronic bk. |9 978-1-84692-035-6 | ||
| 020 | |a 9781846926129 |9 978-1-84692-612-9 | ||
| 035 | |a (OCoLC)693761615 | ||
| 035 | |a (DE-599)BVBBV043161160 | ||
| 040 | |a DE-604 |b ger |e aacr | ||
| 041 | 0 | |a eng | |
| 049 | |a DE-1046 |a DE-1047 | ||
| 082 | 0 | |a 616.898 | |
| 100 | 1 | |a Mortimer, A. M. |e Verfasser |4 aut | |
| 245 | 1 | 0 | |a Therapeutic Strategies in Schizophrenia |
| 264 | 1 | |a Oxford |b Clinical Pub. |c 2010 | |
| 300 | |a 1 Online-Ressource (251 pages) | ||
| 336 | |b txt |2 rdacontent | ||
| 337 | |b c |2 rdamedia | ||
| 338 | |b cr |2 rdacarrier | ||
| 490 | 0 | |a Therapeutic strategies | |
| 500 | |a Contents; Editors; Contributors; Preface; Chapter 1: Medical side-effects of antipsychotic agents: hyperprolactinaemia and metabolic disorders; Chapter 2: Dual diagnosis; Chapter 3: Long-acting antipsychotic injections; Chapter 4: Novel antipsychotic drugs: the current climate; Chapter 5: Cognitive therapy for schizophrenia: does it work?; Chapter6: Treatment strategies in early psychosis; Chapter 7: Structural and functional brain imaging in schizophrenia: implications for pathophysiology; Chapter 8: Functional imaging with ligands in schizophrenia: therapeutic inferences | ||
| 500 | |a Chapter 9: When monotherapy is insufficient: the role and effectiveness of additional drugs in schizophreniaChapter 10: The current status of clozapine in and beyond treatment-resistant schizophrenia; Chapter 11: Neurochemical theories of schizophrenia; Chapter 12: Second-generation atypical versus first generation conventional antipsychotic drug treatment in schizophrenia: another triumph of hope over experience?; Chapter 13: Second-generation antipsychotic drugs: mechanistically distinct or minor variants?; Chapter 14: Disturbed behaviour and its management; Abbreviations; Index | ||
| 500 | |a Updates the reader on the therapeutic options available for the management of schizophrenia, aiding the clinician to translate scientific evidence into improved outcomes. This book also presents a thorough discussion of the new generation of 'atypical' antipsychotic drugs - their mode of action and their clinical efficacy in a range of applications. These new agents are compared with existing medications, guiding the reader on their use in combination with other treatments as part of an integrated programme of patient management. Additional special topics covered include metabolic side-effects | ||
| 500 | |a Includes bibliographical references and index | ||
| 650 | 4 | |a Medicine | |
| 650 | 7 | |a PSYCHOLOGY / Psychopathology / Schizophrenia |2 bisacsh | |
| 650 | 7 | |a Schizophrenia / Treatment |2 fast | |
| 650 | 4 | |a Medizin | |
| 650 | 4 | |a Schizophrenia |x Treatment | |
| 700 | 1 | |a McKenna, P. |e Sonstige |4 oth | |
| 856 | 4 | 0 | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=343867 |x Aggregator |3 Volltext |
| 912 | |a ZDB-4-EBA | ||
| 999 | |a oai:aleph.bib-bvb.de:BVB01-028585351 | ||
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=343867 |l FAW01 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
| 966 | e | |u http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=343867 |l FAW02 |p ZDB-4-EBA |q FAW_PDA_EBA |x Aggregator |3 Volltext | |
Datensatz im Suchindex
| _version_ | 1804175631586426880 |
|---|---|
| any_adam_object | |
| author | Mortimer, A. M. |
| author_facet | Mortimer, A. M. |
| author_role | aut |
| author_sort | Mortimer, A. M. |
| author_variant | a m m am amm |
| building | Verbundindex |
| bvnumber | BV043161160 |
| collection | ZDB-4-EBA |
| ctrlnum | (OCoLC)693761615 (DE-599)BVBBV043161160 |
| dewey-full | 616.898 |
| dewey-hundreds | 600 - Technology (Applied sciences) |
| dewey-ones | 616 - Diseases |
| dewey-raw | 616.898 |
| dewey-search | 616.898 |
| dewey-sort | 3616.898 |
| dewey-tens | 610 - Medicine and health |
| discipline | Medizin |
| format | Electronic eBook |
| fullrecord | <?xml version="1.0" encoding="UTF-8"?><collection xmlns="http://www.loc.gov/MARC21/slim"><record><leader>03555nmm a2200481zc 4500</leader><controlfield tag="001">BV043161160</controlfield><controlfield tag="003">DE-604</controlfield><controlfield tag="005">00000000000000.0</controlfield><controlfield tag="007">cr|uuu---uuuuu</controlfield><controlfield tag="008">151126s2010 |||| o||u| ||||||eng d</controlfield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1846920353</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">1-84692-035-3</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">1846926122</subfield><subfield code="9">1-84692-612-2</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781846920356</subfield><subfield code="c">electronic bk.</subfield><subfield code="9">978-1-84692-035-6</subfield></datafield><datafield tag="020" ind1=" " ind2=" "><subfield code="a">9781846926129</subfield><subfield code="9">978-1-84692-612-9</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(OCoLC)693761615</subfield></datafield><datafield tag="035" ind1=" " ind2=" "><subfield code="a">(DE-599)BVBBV043161160</subfield></datafield><datafield tag="040" ind1=" " ind2=" "><subfield code="a">DE-604</subfield><subfield code="b">ger</subfield><subfield code="e">aacr</subfield></datafield><datafield tag="041" ind1="0" ind2=" "><subfield code="a">eng</subfield></datafield><datafield tag="049" ind1=" " ind2=" "><subfield code="a">DE-1046</subfield><subfield code="a">DE-1047</subfield></datafield><datafield tag="082" ind1="0" ind2=" "><subfield code="a">616.898</subfield></datafield><datafield tag="100" ind1="1" ind2=" "><subfield code="a">Mortimer, A. M.</subfield><subfield code="e">Verfasser</subfield><subfield code="4">aut</subfield></datafield><datafield tag="245" ind1="1" ind2="0"><subfield code="a">Therapeutic Strategies in Schizophrenia</subfield></datafield><datafield tag="264" ind1=" " ind2="1"><subfield code="a">Oxford</subfield><subfield code="b">Clinical Pub.</subfield><subfield code="c">2010</subfield></datafield><datafield tag="300" ind1=" " ind2=" "><subfield code="a">1 Online-Ressource (251 pages)</subfield></datafield><datafield tag="336" ind1=" " ind2=" "><subfield code="b">txt</subfield><subfield code="2">rdacontent</subfield></datafield><datafield tag="337" ind1=" " ind2=" "><subfield code="b">c</subfield><subfield code="2">rdamedia</subfield></datafield><datafield tag="338" ind1=" " ind2=" "><subfield code="b">cr</subfield><subfield code="2">rdacarrier</subfield></datafield><datafield tag="490" ind1="0" ind2=" "><subfield code="a">Therapeutic strategies</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Contents; Editors; Contributors; Preface; Chapter 1: Medical side-effects of antipsychotic agents: hyperprolactinaemia and metabolic disorders; Chapter 2: Dual diagnosis; Chapter 3: Long-acting antipsychotic injections; Chapter 4: Novel antipsychotic drugs: the current climate; Chapter 5: Cognitive therapy for schizophrenia: does it work?; Chapter6: Treatment strategies in early psychosis; Chapter 7: Structural and functional brain imaging in schizophrenia: implications for pathophysiology; Chapter 8: Functional imaging with ligands in schizophrenia: therapeutic inferences</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Chapter 9: When monotherapy is insufficient: the role and effectiveness of additional drugs in schizophreniaChapter 10: The current status of clozapine in and beyond treatment-resistant schizophrenia; Chapter 11: Neurochemical theories of schizophrenia; Chapter 12: Second-generation atypical versus first generation conventional antipsychotic drug treatment in schizophrenia: another triumph of hope over experience?; Chapter 13: Second-generation antipsychotic drugs: mechanistically distinct or minor variants?; Chapter 14: Disturbed behaviour and its management; Abbreviations; Index</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Updates the reader on the therapeutic options available for the management of schizophrenia, aiding the clinician to translate scientific evidence into improved outcomes. This book also presents a thorough discussion of the new generation of 'atypical' antipsychotic drugs - their mode of action and their clinical efficacy in a range of applications. These new agents are compared with existing medications, guiding the reader on their use in combination with other treatments as part of an integrated programme of patient management. Additional special topics covered include metabolic side-effects</subfield></datafield><datafield tag="500" ind1=" " ind2=" "><subfield code="a">Includes bibliographical references and index</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medicine</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">PSYCHOLOGY / Psychopathology / Schizophrenia</subfield><subfield code="2">bisacsh</subfield></datafield><datafield tag="650" ind1=" " ind2="7"><subfield code="a">Schizophrenia / Treatment</subfield><subfield code="2">fast</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Medizin</subfield></datafield><datafield tag="650" ind1=" " ind2="4"><subfield code="a">Schizophrenia</subfield><subfield code="x">Treatment</subfield></datafield><datafield tag="700" ind1="1" ind2=" "><subfield code="a">McKenna, P.</subfield><subfield code="e">Sonstige</subfield><subfield code="4">oth</subfield></datafield><datafield tag="856" ind1="4" ind2="0"><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=343867</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="912" ind1=" " ind2=" "><subfield code="a">ZDB-4-EBA</subfield></datafield><datafield tag="999" ind1=" " ind2=" "><subfield code="a">oai:aleph.bib-bvb.de:BVB01-028585351</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=343867</subfield><subfield code="l">FAW01</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield><datafield tag="966" ind1="e" ind2=" "><subfield code="u">http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=343867</subfield><subfield code="l">FAW02</subfield><subfield code="p">ZDB-4-EBA</subfield><subfield code="q">FAW_PDA_EBA</subfield><subfield code="x">Aggregator</subfield><subfield code="3">Volltext</subfield></datafield></record></collection> |
| id | DE-604.BV043161160 |
| illustrated | Not Illustrated |
| indexdate | 2024-07-10T07:19:22Z |
| institution | BVB |
| isbn | 1846920353 1846926122 9781846920356 9781846926129 |
| language | English |
| oai_aleph_id | oai:aleph.bib-bvb.de:BVB01-028585351 |
| oclc_num | 693761615 |
| open_access_boolean | |
| owner | DE-1046 DE-1047 |
| owner_facet | DE-1046 DE-1047 |
| physical | 1 Online-Ressource (251 pages) |
| psigel | ZDB-4-EBA ZDB-4-EBA FAW_PDA_EBA |
| publishDate | 2010 |
| publishDateSearch | 2010 |
| publishDateSort | 2010 |
| publisher | Clinical Pub. |
| record_format | marc |
| series2 | Therapeutic strategies |
| spelling | Mortimer, A. M. Verfasser aut Therapeutic Strategies in Schizophrenia Oxford Clinical Pub. 2010 1 Online-Ressource (251 pages) txt rdacontent c rdamedia cr rdacarrier Therapeutic strategies Contents; Editors; Contributors; Preface; Chapter 1: Medical side-effects of antipsychotic agents: hyperprolactinaemia and metabolic disorders; Chapter 2: Dual diagnosis; Chapter 3: Long-acting antipsychotic injections; Chapter 4: Novel antipsychotic drugs: the current climate; Chapter 5: Cognitive therapy for schizophrenia: does it work?; Chapter6: Treatment strategies in early psychosis; Chapter 7: Structural and functional brain imaging in schizophrenia: implications for pathophysiology; Chapter 8: Functional imaging with ligands in schizophrenia: therapeutic inferences Chapter 9: When monotherapy is insufficient: the role and effectiveness of additional drugs in schizophreniaChapter 10: The current status of clozapine in and beyond treatment-resistant schizophrenia; Chapter 11: Neurochemical theories of schizophrenia; Chapter 12: Second-generation atypical versus first generation conventional antipsychotic drug treatment in schizophrenia: another triumph of hope over experience?; Chapter 13: Second-generation antipsychotic drugs: mechanistically distinct or minor variants?; Chapter 14: Disturbed behaviour and its management; Abbreviations; Index Updates the reader on the therapeutic options available for the management of schizophrenia, aiding the clinician to translate scientific evidence into improved outcomes. This book also presents a thorough discussion of the new generation of 'atypical' antipsychotic drugs - their mode of action and their clinical efficacy in a range of applications. These new agents are compared with existing medications, guiding the reader on their use in combination with other treatments as part of an integrated programme of patient management. Additional special topics covered include metabolic side-effects Includes bibliographical references and index Medicine PSYCHOLOGY / Psychopathology / Schizophrenia bisacsh Schizophrenia / Treatment fast Medizin Schizophrenia Treatment McKenna, P. Sonstige oth http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=343867 Aggregator Volltext |
| spellingShingle | Mortimer, A. M. Therapeutic Strategies in Schizophrenia Medicine PSYCHOLOGY / Psychopathology / Schizophrenia bisacsh Schizophrenia / Treatment fast Medizin Schizophrenia Treatment |
| title | Therapeutic Strategies in Schizophrenia |
| title_auth | Therapeutic Strategies in Schizophrenia |
| title_exact_search | Therapeutic Strategies in Schizophrenia |
| title_full | Therapeutic Strategies in Schizophrenia |
| title_fullStr | Therapeutic Strategies in Schizophrenia |
| title_full_unstemmed | Therapeutic Strategies in Schizophrenia |
| title_short | Therapeutic Strategies in Schizophrenia |
| title_sort | therapeutic strategies in schizophrenia |
| topic | Medicine PSYCHOLOGY / Psychopathology / Schizophrenia bisacsh Schizophrenia / Treatment fast Medizin Schizophrenia Treatment |
| topic_facet | Medicine PSYCHOLOGY / Psychopathology / Schizophrenia Schizophrenia / Treatment Medizin Schizophrenia Treatment |
| url | http://search.ebscohost.com/login.aspx?direct=true&scope=site&db=nlebk&db=nlabk&AN=343867 |
| work_keys_str_mv | AT mortimeram therapeuticstrategiesinschizophrenia AT mckennap therapeuticstrategiesinschizophrenia |